Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial

Authors :: Garg, Amit X
Al-Jaishi, Ahmed A
Dixon, Stephanie N
Sontrop, Jessica M
Anderson, Sierra J
Bagga, Amit
Benjamin, Derek S
Berry, William AD
Blake, Peter G
Chambers, Laura C
Chan, Patricia CK
Delbrouck, Nicole F
Devereaux, Philip J
Goluch, Richard J
Gregor, Laura H
Grimshaw, Jeremy M
Hanson, Garth J
Illiescu, Eduard A
Jain, Arsh K
Killin, Lauren
Lok, Charmaine E
Luo, Bin
Mustafa, Reem A
Nathoo, Bharat C
Nesrallah, Gihad E
Oliver, Matt J
Pandeya, Sanjay
Parmar, Malvinder S
Perkins, David N
Presseau, Justin
Rabin, Elijah Z
Sasal, Joanna T
Shulman, Tanya S
Smith, D Michael
Sood, Manish
Steele, Andrew W
Tam, Paul YW
Tascona, Daniel J
Wadehra, Davinder B
Wald, Ron
Walsh, Michael
Watson, Paul A
Wodchis, Walter P
Zager, Philip G
Zwarenstein, Merrick
McIntyre, Christopher W
Source :: The Lancet; November 2022, Vol. 400 Issue: 10364 p1693-1703, 11p
Publication Year :: 2022
Abstract: Haemodialysis centres have conventionally provided maintenance haemodialysis using a standard dialysate temperature (eg, 36·5°C) for all patients. Many centres now use cooler dialysate (eg, 36·0°C or lower) for potential cardiovascular benefits. We aimed to assess whether personalised cooler dialysate, implemented as centre-wide policy, reduced the risk of cardiovascular-related death or hospital admission compared with standard temperature dialysate.

Full Text Access

Tools